Full-Time

Territory Business Manager

Posted on 4/2/2025

Heron Therapeutics

Heron Therapeutics

201-500 employees

Compensation Overview

$135k - $175k/yr

+ Bonus

Mid, Senior

Orlando, FL, USA

Category
Field Sales
Sales & Account Management
Requirements
  • B.S. degree in a relevant field highly preferred. Will consider experience in lieu of degree.
  • Minimum three (3) or more years of account management experience in medical device sales and/or pharmaceutical sales targeting surgeons. Will consider other relevant experience in lieu of account management that demonstrates the ability to build and maintain strong professional relationships with surgeons across multiple specialties. Experience targeting anesthesiologists a definite plus.
  • Pharmaceutical hospital sales experience with P&T process is strongly preferred. Experience selling to or partnering with pharmacists a definite plus.
  • Experience selling in an orthopedic and general surgery setting. Pain management preferred.
  • Minimum one (1) year of demonstrated experience working alongside physicians and staff in the operating room.
  • Demonstrated strong business skills to understand and analyze business and market drivers, and develop, execute, and adjust business plans.
  • Demonstrated experience getting products into protocols/standing orders and experience with general pull-through.
  • Demonstrated ability to ask strategic, insightful questions to obtain information on customer needs from all stakeholders and develop successful business plans.
  • Demonstrated in-depth knowledge of how to create a compelling and logical rationale for the value of products and how to contrast, compare, and position Heron’s acute care products compliantly versus the competition.
  • Ability to communicate a current, effective, and accurate sales presentation to customers.
  • Ability to understand and retain comprehensive knowledge of information regarding pain management and PONV practices, related disease states, and associated patient care.
  • Candidates must satisfy reasonable credentialing requirements, including, but not limited to vaccinations and background checks, where applicable.
  • Must be available to work in the evenings and weekends, as required. Early mornings in the OR are frequently required.
  • This is a full time field position requiring 100% customer focus. Must be willing to travel by car or plane as needed to visit customers, and attend conferences, or corporate meetings. Must possess a valid motor vehicle operator’s license in good standing.
Responsibilities
  • Meet or exceed all established territory sales goals, managing to budgets by developing and implementing strategies specific to the assigned territory that aligns to the overall commercial brand strategy and reflect an in-depth understanding of local market forces.
  • Establish and maintain professional relationships with the decision-makers and key contacts (e.g. surgeons, anesthesiologists, pharmacy directors) in hospital & ASCs, developing buy-in and support for Heron’s acute care portfolio.
  • Develop and implement strategies to ensure Heron’s acute care products are on hospital formulary as well as in EMR systems, on protocols and standing orders.
  • Engage in informed discussions and communicate a compliant, current, effective, on-message and accurate sales presentation to customers. Customize interactions based on individual customer needs and perspectives.
  • Develop and implement special programs within territory to maximize sales opportunities, i.e. peer-to-peer programs, etc.
  • Verbally deliver clear and concise instruction on the safe and efficacious use of Heron acute care products to customers in and out of the operating room setting, including in-services for surgeons and clinical staff.
  • Maintain an updated working knowledge of Heron’s acute care products, relevant disease states, and competitor products in order to provide comprehensive clinical knowledge to customer contacts.
  • Able to carry out all duties and responsibilities in compliance with applicable regulations and Pharma guidelines. Complete assigned administrative tasks, including customer records, in a timely, accurate, legible, and organized manner complying with all corporate policies, procedures, and standards.
Desired Qualifications
  • Experience targeting anesthesiologists a definite plus.
  • Pharmaceutical hospital sales experience with P&T process is strongly preferred. Experience selling to or partnering with pharmacists a definite plus.
  • Experience selling in an orthopedic and general surgery setting. Pain management preferred.

Company Size

201-500

Company Stage

IPO

Headquarters

San Diego, California

Founded

1983

Simplify Jobs

Simplify's Take

What believers are saying

  • ZYNRELEF's inclusion in NOPAIN Act could boost market adoption and revenue.
  • Relocation to Cary may facilitate strategic partnerships and talent acquisition.
  • Acadian Asset Management's investment indicates confidence in Heron's growth potential.

What critics are saying

  • Competition in non-opioid pain relief market may impact Heron's market share.
  • ZYNRELEF's reimbursement challenges may arise if proposed rule is delayed.
  • Relocation to Cary may cause operational disruptions and potential loss of key personnel.

What makes Heron Therapeutics unique

  • Heron focuses on non-opioid pain management, highlighted by ZYNRELEF's inclusion in NOPAIN Act.
  • Relocation to Cary, NC, positions Heron in a prominent biotech hub for growth.
  • Michael Kaseta's board appointment strengthens Heron's strategic direction with biopharma expertise.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

Company News

PR Newswire
Feb 27th, 2025
Heron Therapeutics Announces Fourth Quarter And Full-Year 2024 Financial Results And Highlights Recent Corporate Updates

Achieved Q4 2024 GAAP Net Income of $3.6 million. Generated full-year 2024 Net Revenue of $144.2 million, up 14% year-over-year. Delivered full-year 2024 adjusted EBITDA of $8.6 million

PR Newswire
Feb 13th, 2025
Heron Therapeutics To Report Fourth Quarter And Full Year 2024 Financial Results On Thursday, February 27, 2025

CARY, N.C., Feb. 13, 2025 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Thursday, February 27, 2025, at 8:00 a.m. ET to report fourth quarter and full year 2024 financial results and discuss recent business highlights.The conference call can be accessed by phone by utilizing the following registration link which will provide participants with dial-in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The conference call will also be available via webcast under the Investor Relations section of Heron's website at www.herontx.com

North Carolina Biotechnology Center
Dec 30th, 2024
Heron to move headquarters from California to Cary, NC

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, will relocate its headquarters from San Diego, California, to Cary, North Carolina, effective Jan. 1, 2025, according to a recent company announcement.

PR Newswire
Dec 23rd, 2024
Heron Therapeutics Announces Corporate Headquarters Relocation To Cary, North Carolina

SAN DIEGO, Dec. 23, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, announced today the relocation of the Company's headquarters from San Diego, California to Cary, North Carolina, effective January 1, 2025. A majority of Heron's Management Team and corporate employees work from the Cary office, which is near the Research Triangle Park ("RTP"), one of the most prominent high-tech research and development parks in the United States. The growing biotech community in Cary and its surrounding areas provides ample space for growth and expansion."We are excited to move our headquarters to Cary, North Carolina, which represents a significant milestone in Heron's journey," said Craig Collard, Chief Executive Officer of Heron. "This move will not only strengthen our ability to support our employees by centralizing our operations and resources, but also positions us in an excellent location from which we can continue making strategic partnerships as we growing our existing portfolio focused on improving the lives of patients in the acute and oncology care settings

Stock Titan
Dec 23rd, 2024
Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina

Heron Therapeutics (HRTX) announced the relocation of its corporate headquarters from San Diego, California to Cary, North Carolina, effective January 1, 2025.

INACTIVE